Clinical Trials in Los Angeles

Showing 2801-2820 of 14,465 trials

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

NCT06188208

A FIH study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of VVD-130850, as single agent and in combination with checkpoint inhibition, in participants with advanced solid and hematologic tumors.

Advanced Solid TumorsAdvanced Hematologic Tumors

Vividion Therapeutics, Inc.125 participantsStarted Jan 2024

Los Angeles, California, United States • Sarasota, Florida, United States • Nashville, Tennessee, United States +17 more locations

COMPLETEDPhase 1/2< 1 mile

A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

NCT05027139

This study is being done to find out if zanidatamab when given with evorpacept (ALX148) is safe and can treat patients with advanced (locally advanced \[inoperable\] and/or metastatic) human epidermal growth factor receptor 2 (HER2)-expressing cancer.

HER2-expressing Cancers

Jazz Pharmaceuticals52 participantsStarted Sep 2021

La Jolla, California, United States • Los Angeles, California, United States • Orange, California, United States +8 more locations

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors

A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing Cancer

Find Trials by Condition in Los Angeles

Epigenetic Reprogramming in Relapse/Refractory AML

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

PERIGON Pivotal Trial

Biliary Atresia Study in Infants and Children

Longitudinal Study of Mitochondrial Hepatopathies

Nafamostat Efficacy in Phase 3 Registrational CRRT Study

Study of EYP-1901 in Subjects With Wet Age Related Macular Degeneration (wAMD)

A Study of Islatravir (ISL) and Ulonivirine (ULO) Once Weekly (QW) in Virologically Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8591B-060)

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Treating Pain in Children With Cancer: Pain Buddy

A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis

SUBLOCADE Long-term Outcomes

Phase II of Neoadjuvant and Adjuvant Capmatinib in NSCLC

Greenlight Plus Study: Approaches to Early Childhood Obesity Prevention

Carboplatin and Paclitaxel With or Without Atezolizumab Before Surgery in Treating Patients With Newly Diagnosed, Stage II-III Triple-Negative Breast Cancer

An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)